These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
148 related articles for article (PubMed ID: 8414186)
1. The NMDA receptor antagonist MK-801 markedly reduces the induction of c-fos gene by haloperidol in the mouse striatum. Ziólkowska B; Höllt V Neurosci Lett; 1993 Jun; 156(1-2):39-42. PubMed ID: 8414186 [TBL] [Abstract][Full Text] [Related]
2. Role of NR2B-containing N-methyl-D-aspartate receptors in haloperidol-induced c-Fos expression in the striatum and nucleus accumbens. Lee J; Rajakumar N Neuroscience; 2003; 122(3):739-45. PubMed ID: 14622917 [TBL] [Abstract][Full Text] [Related]
3. Glutamatergic regulation of haloperidol-induced c-fos expression in the rat striatum and nucleus accumbens. Hussain N; Flumerfelt BA; Rajakumar N Neuroscience; 2001; 102(2):391-9. PubMed ID: 11166125 [TBL] [Abstract][Full Text] [Related]
4. Role of NMDA receptor subtypes in the induction of catalepsy and increase in Fos protein expression after administration of haloperidol. Yanahashi S; Hashimoto K; Hattori K; Yuasa S; Iyo M Brain Res; 2004 Jun; 1011(1):84-93. PubMed ID: 15140647 [TBL] [Abstract][Full Text] [Related]
5. Caffeine-induced expression of c-fos mRNA and NGFI-A mRNA in caudate putamen and in nucleus accumbens are differentially affected by the N-methyl-D-aspartate receptor antagonist MK-801. Svenningsson P; Johansson B; Fredholm BB Brain Res Mol Brain Res; 1996 Jan; 35(1-2):183-9. PubMed ID: 8717354 [TBL] [Abstract][Full Text] [Related]
6. Fos is not involved in the regulation of the proenkephalin gene by haloperidol in the mouse striatum. Ziółkowska B; Höllt V Brain Res Mol Brain Res; 1995 Dec; 34(2):351-4. PubMed ID: 8750842 [TBL] [Abstract][Full Text] [Related]
7. Role of adenosine and N-methyl-D-aspartate receptors in mediating haloperidol-induced gene expression and catalepsy. Chartoff EH; Ward RP; Dorsa DM J Pharmacol Exp Ther; 1999 Nov; 291(2):531-7. PubMed ID: 10525068 [TBL] [Abstract][Full Text] [Related]
8. Cortical stimulation induces Fos expression in striatal neurons via NMDA glutamate and dopamine receptors. Liste I; Rozas G; Guerra MJ; Labandeira-Garcia JL Brain Res; 1995 Nov; 700(1-2):1-12. PubMed ID: 8624698 [TBL] [Abstract][Full Text] [Related]
9. NMDA receptor overstimulation triggers a prolonged wave of immediate early gene expression: relationship to excitotoxicity. Shan Y; Carlock LR; Walker PD Exp Neurol; 1997 Apr; 144(2):406-15. PubMed ID: 9168840 [TBL] [Abstract][Full Text] [Related]
10. Induction and suppression of immediate early genes in specific rat brain regions by the non-competitive N-methyl-D-aspartate receptor antagonist MK-801. Gass P; Herdegen T; Bravo R; Kiessling M Neuroscience; 1993 Apr; 53(3):749-58. PubMed ID: 8487953 [TBL] [Abstract][Full Text] [Related]
11. D2 dopamine receptor antagonists induce fos and related proteins in rat striatal neurons. Dragunow M; Robertson GS; Faull RL; Robertson HA; Jansen K Neuroscience; 1990; 37(2):287-94. PubMed ID: 1966822 [TBL] [Abstract][Full Text] [Related]
12. NMDA receptor-mediated expression of Fos protein in the rat striatum following methamphetamine administration: relation to behavioral sensitization. Ohno M; Yoshida H; Watanabe S Brain Res; 1994 Nov; 665(1):135-40. PubMed ID: 7882006 [TBL] [Abstract][Full Text] [Related]
13. Morphine induces c-fos and junB in striatum and nucleus accumbens via D1 and N-methyl-D-aspartate receptors. Liu J; Nickolenko J; Sharp FR Proc Natl Acad Sci U S A; 1994 Aug; 91(18):8537-41. PubMed ID: 8078918 [TBL] [Abstract][Full Text] [Related]
14. Nicotine induced c-fos expression in the striatum is mediated mostly by dopamine D1 receptor and is dependent on NMDA stimulation. Kiba H; Jayaraman A Brain Res Mol Brain Res; 1994 Apr; 23(1-2):1-13. PubMed ID: 7913201 [TBL] [Abstract][Full Text] [Related]
15. Degree of immediate early gene induction in striatum by eticlopride determines sensitivity to N-methyl-D-aspartate receptor blockade. Adams AC; Keefe KA Brain Res; 2000 Dec; 885(2):201-7. PubMed ID: 11102574 [TBL] [Abstract][Full Text] [Related]
16. Dopamine is not required for the hyperlocomotor response to NMDA receptor antagonists. Chartoff EH; Heusner CL; Palmiter RD Neuropsychopharmacology; 2005 Jul; 30(7):1324-33. PubMed ID: 15688082 [TBL] [Abstract][Full Text] [Related]
17. Dopamine D2-like antagonists induce chromatin remodeling in striatal neurons through cyclic AMP-protein kinase A and NMDA receptor signaling. Li J; Guo Y; Schroeder FA; Youngs RM; Schmidt TW; Ferris C; Konradi C; Akbarian S J Neurochem; 2004 Sep; 90(5):1117-31. PubMed ID: 15312167 [TBL] [Abstract][Full Text] [Related]
18. Regulation of cholecystokinin mRNA content in rat striatum: a glutamatergic hypothesis. Ding XZ; Mocchetti I J Pharmacol Exp Ther; 1992 Oct; 263(1):368-73. PubMed ID: 1403798 [TBL] [Abstract][Full Text] [Related]
19. Role of NMDA glutamate receptors in regulating D2 dopamine-dependent Fos induction in the rat striatopallidal pathway. Pollack AE; Bird JL; Lambert EB; Florin ZP; Castellar VL Brain Res; 1999 Feb; 818(2):543-7. PubMed ID: 10082844 [TBL] [Abstract][Full Text] [Related]
20. NMDA receptor blockade attenuates the haloperidol induction of Fos protein in the dorsal but not the ventral striatum. de Souza IE; Meredith GE Synapse; 1999 Jun; 32(4):243-53. PubMed ID: 10332800 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]